123 related articles for article (PubMed ID: 8957552)
41. [Analysis of proliferating cell nuclear antigen (PCNA) expression in 24 cases of primary non-small cell pulmonary carcinomas and correlation with survival].
Castellano VM; Sotelo T; Ballestín C; López-Encuentra A; Varela G
Arch Bronconeumol; 1996 Mar; 32(3):127-31. PubMed ID: 8634790
[TBL] [Abstract][Full Text] [Related]
42. [Immunohistochemical study of proliferating cell nuclear antigen (PCNA) in gynecological tumors and their related lesions].
Sawada M; Ueda G; Inoue M; Shimizu H; Ogawa H; Nakazawa A; Fujita M; Tanizawa O; Tsujimoto M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):181-7. PubMed ID: 1347557
[TBL] [Abstract][Full Text] [Related]
43. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method.
Alexiev BA
Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580
[TBL] [Abstract][Full Text] [Related]
44. Heat-induced antigen retrieval of proliferating cell nuclear antigen and p53 protein in formalin-fixed, paraffin-embedded sections.
Kawai K; Serizawa A; Hamana T; Tsutsumi Y
Pathol Int; 1994; 44(10-11):759-64. PubMed ID: 7834077
[TBL] [Abstract][Full Text] [Related]
45. Placental glutathione S-transferase correlates with cellular proliferation during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.
Silva RN; Ribeiro DA; Salvadori DM; Marques ME
Exp Toxicol Pathol; 2007 Sep; 59(1):61-8. PubMed ID: 17596925
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study.
Yan JJ; Tzeng CC; Jin YT
J Oral Pathol Med; 1996 Feb; 25(2):55-9. PubMed ID: 8667256
[TBL] [Abstract][Full Text] [Related]
47. Assessment of proliferating cell nuclear antigen immunostaining in parotid tumors.
Takahashi M; Adachi T; Matsui R; Miyokawa N
Eur Arch Otorhinolaryngol; 1998; 255(6):311-4. PubMed ID: 9693928
[TBL] [Abstract][Full Text] [Related]
48. [Quantitative observation of expression of proliferation cell nuclear antigen in nasopharyngeal carcinoma].
Du B; Du B; Zhang Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Feb; 32(1):21-3. PubMed ID: 10743121
[TBL] [Abstract][Full Text] [Related]
49. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
50. Growth kinetic study of human hepatocellular carcinoma using proliferating cell nuclear antigen and Lewis Y antigen: their correlation with transforming growth factor-alpha and beta 1.
Yamaguchi M; Yu L; Hishikawa Y; Yamanoi A; Kubota H; Nagasue N
Oncology; 1997; 54(3):245-51. PubMed ID: 9143407
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
52. Troubleshooting immunohistochemical labelling of proliferating cell nuclear antigen (PCNA) in cryocut tissue sections of mouse prostate.
Xie JH; Hollande F; Haynes JM; Pouton CW; Ventura S
J Pharmacol Toxicol Methods; 2010; 61(2):98-101. PubMed ID: 19945538
[TBL] [Abstract][Full Text] [Related]
53. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays.
Kennedy AS; Raleigh JA; Perez GM; Calkins DP; Thrall DE; Novotny DB; Varia MA
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):897-905. PubMed ID: 9128967
[TBL] [Abstract][Full Text] [Related]
54. The expression of proliferating cell nuclear antigen in hepatocellular carcinoma.
Wu JD; Tseng HH
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):198-203. PubMed ID: 7911731
[TBL] [Abstract][Full Text] [Related]
55. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
56. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
57. Assessment of proliferating cell nuclear antigen (PCNA) in breast cancer using anti-PCNA PC10 and 19A2: correlation with 5-bromo-2'-deoxyuridine or tritiated thymidine labeling and flow cytometric analysis.
He W; Meyer JS; Scrivner DL; Koehm S; Hughes J
Biotech Histochem; 1994 Jul; 69(4):203-12. PubMed ID: 7918835
[TBL] [Abstract][Full Text] [Related]
58. A look at the biology of spindle cell squamous carcinoma of the oral cavity: report of a case.
Rizzardi C; Frezzini C; Maglione M; Tirelli G; Melato M
J Oral Maxillofac Surg; 2003 Feb; 61(2):264-8. PubMed ID: 12619009
[No Abstract] [Full Text] [Related]
59. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
[TBL] [Abstract][Full Text] [Related]
60. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
